Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

6.11
Delayed Data
As of May 04
 +0.09 / +1.50%
Today’s Change
2.57
Today|||52-Week Range
10.00
+37.61%
Year-to-Date
No recent news for Titan Pharmaceuticals Inc.

Today’s Trading

Previous close6.02
Today’s open6.02
Day’s range5.96 - 6.18
Volume105,127
Average volume (3 months)258,368
Market cap$120.8M
Dividend yield--
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-154.55%
Earnings growth (this year)+148.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-54.17%
P/E ratioNM
Price/Sales53.28
Price/Book17.28

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.20-3.20%
PRQRProQR Therapeutics N...-0.48-9.27%
AGLEAeglea Bio Therapeut...-0.30-3.19%
ORMPOramed Pharmaceutica...+0.55+6.15%
Data as of 3:59pm ET, 05/04/2016

Financials

Next reporting dateMay 11, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$1.7M
Annual profit (last year)-$11.3M
Net profit margin-674.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Secretary &
Director
Sunil Bhonsle
Vice President-
Finance
Brian Crowley
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs